Q7Z7D3 (VTCN1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 85.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: V-set domain-containing T-cell activation inhibitor 1 Alternative name(s): B7h.5 Immune costimulatory protein B7-H4 Protein B7S1 T-cell costimulatory molecule B7x | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 282 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation. Ref.12 Ref.13 Ref.16 Ref.17 UniProtKB Q7TSP5 |
| Subcellular location | Cell membrane; Single-pass type I membrane protein Potential. Note: Expressed at the cell surface. A soluble form has also been detected. Ref.1 Ref.3 Ref.12 |
| Tissue specificity | Overexpressed in breast, ovarian, endometrial, renal cell (RCC) and non-small-cell lung cancers (NSCLC). Expressed on activated T- and B-cells, monocytes and dendritic cells, but not expressed in most normal tissues (at protein level). Widely expressed, including in kidney, liver, lung, ovary, placenta, spleen and testis. Ref.1 Ref.3 Ref.11 Ref.12 Ref.13 Ref.15 Ref.17 |
| Induction | Up-regulated by IL6/interleukin-6 and IL10/interleukin-10 and inhibited by CSF2/GM-CSF and IL4/interleukin-4 on antigen-presenting cells (APCs). Ref.13 Ref.14 Ref.16 |
| Post-translational modification | N-glycosylated. Ref.12 |
| Miscellaneous | May serve as a predictive marker for renal cell carcinoma. Ref.15 |
| Sequence similarities | Belongs to the immunoglobulin superfamily. BTN/MOG family. UniProtKB Q5ZPR3 Contains 2 Ig-like V-type (immunoglobulin-like) domains. |
| Caution | The mouse ortholog has been shown (PubMed:12818166) to be a GPI-anchored protein but the Gly residue which is predicted to be the modified site in mouse and rat is not conserved in human. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Adaptive immunity Immunity |
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Alternative splicing |
| Domain | Immunoglobulin domain Repeat Signal Transmembrane Transmembrane helix |
| PTM | Disulfide bond Glycoprotein Lipoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Cellular component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 Ref.1 Ref.2 Ref.3 Ref.5 Ref.6 Ref.7 Ref.8 Ref.9 Ref.10 (identifier: Q7Z7D3-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 Ref.3 (identifier: Q7Z7D3-2) The sequence of this isoform differs from the canonical sequence as follows: 33-148: Missing. | ||||||
| Isoform 3 Ref.4 (identifier: Q7Z7D3-3) The sequence of this isoform differs from the canonical sequence as follows: 33-87: GRHSITVTTV...GLVHEFKEGK → EVSVWLSAMK...WGGWNPELHF 88-282: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 24 | 24 | Potential | ||||||||
| Chain | 25 – 282 | 258 | V-set domain-containing T-cell activation inhibitor 1 | PRO_0000339237 | |||||||
Regions | |||||||||||
| Topological domain | 25 – 259 | 235 | Extracellular Potential | ||||||||
| Transmembrane | 260 – 280 | 21 | Helical; Potential | ||||||||
| Topological domain | 281 – 282 | 2 | Cytoplasmic Potential | ||||||||
| Domain | 35 – 146 | 112 | Ig-like V-type 1 | ||||||||
| Domain | 153 – 241 | 89 | Ig-like V-type 2 | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 216 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 56 ↔ 130 | By similarity | |||||||||
| Disulfide bond | 168 ↔ 225 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 33 – 148 | 116 | Missing in isoform 2. Ref.3 | VSP_052841 | |||||||
| Alternative sequence | 33 – 87 | 55 | GRHSI…FKEGK → EVSVWLSAMKGWCRSSKASL SIDLCFLNFRETLHHSHYCR LSWEHWGGWNPELHF in isoform 3. Ref.4 | VSP_052842 | |||||||
| Alternative sequence | 88 – 282 | 195 | Missing in isoform 3. Ref.4 | VSP_052843 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 29 | 1 | F → L in ABI16083. Ref.10 | ||||||||
| Sequence conflict | 54 | 1 | L → Q in BAB15349. Ref.6 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "B7-H4, a molecule of the B7 family, negatively regulates T cell immunity." Sica G.L., Choi I.-H., Zhu G., Tamada K., Wang S.-D., Tamura H., Chapoval A.I., Flies D.B., Bajorath J., Chen L. Immunity 18:849-861(2003) [PubMed: 12818165] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Placenta. |
| [2] | "B7x: a widely expressed B7 family member that inhibits T cell activation." Zang X., Loke P., Kim J., Murphy K., Waitz R., Allison J.P. Proc. Natl. Acad. Sci. U.S.A. 100:10388-10392(2003) [PubMed: 12920180] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [3] | "B7-H3 and B7-H4 expression in non-small-cell lung cancer." Sun Y., Wang Y., Zhao J., Gu M., Giscombe R., Lefvert A.K., Wang X. Lung Cancer 53:143-151(2006) [PubMed: 16782226] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [4] | "A new splice variant of B7-H4." Mao Y., Zhang X. Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). |
| [5] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed: 12975309] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [6] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Kidney epithelium. |
| [7] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain. |
| [10] | Huang G., Bai Y., Zhang L., Zhang L., Song M. Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-167 (ISOFORM 1). Tissue: Peripheral blood. |
| [11] | "Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family." Choi I.-H., Zhu G., Sica G.L., Strome S.E., Cheville J.C., Lau J.S., Zhu Y., Flies D.B., Tamada K., Chen L. J. Immunol. 171:4650-4654(2003) [PubMed: 14568939] [Abstract] Cited for: ALTERNATIVE SPLICING, TISSUE SPECIFICITY. |
| [12] | "The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation." Salceda S., Tang T., Kmet M., Munteanu A., Ghosh M., Macina R., Liu W., Pilkington G., Papkoff J. Exp. Cell Res. 306:128-141(2005) [PubMed: 15878339] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, GLYCOSYLATION. |
| [13] | "B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma." Kryczek I., Zou L., Rodriguez P., Zhu G., Wei S., Mottram P., Brumlik M., Cheng P., Curiel T., Myers L., Lackner A., Alvarez X., Ochoa A., Chen L., Zou W. J. Exp. Med. 203:871-881(2006) [PubMed: 16606666] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, INDUCTION. |
| [14] | "Induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells." Kryczek I., Wei S., Zou L., Zhu G., Mottram P., Xu H., Chen L., Zou W. J. Immunol. 177:40-44(2006) [PubMed: 16785496] [Abstract] Cited for: INDUCTION. |
| [15] | "B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival." Krambeck A.E., Thompson R.H., Dong H., Lohse C.M., Park E.S., Kuntz S.M., Leibovich B.C., Blute M.L., Cheville J.C., Kwon E.D. Proc. Natl. Acad. Sci. U.S.A. 103:10391-10396(2006) [PubMed: 16798883] [Abstract] Cited for: TISSUE SPECIFICITY, USE AS A MARKER FOR RENAL CELL CANCER. |
| [16] | "Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma." Kryczek I., Wei S., Zhu G., Myers L., Mottram P., Cheng P., Chen L., Coukos G., Zou W. Cancer Res. 67:8900-8905(2007) [PubMed: 17875732] [Abstract] Cited for: FUNCTION, INDUCTION. |
| [17] | "B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration." Miyatake T., Tringler B., Liu W., Liu S.-H., Papkoff J., Enomoto T., Torkko K.C., Dehn D.L., Swisher A., Shroyer K.R. Gynecol. Oncol. 106:119-127(2007) [PubMed: 17509674] [Abstract] Cited for: FUNCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AY280972 mRNA. Translation: AAP37283.1. AY346100 mRNA. Translation: AAQ24206.1. DQ103757 mRNA. Translation: AAZ17406.1. AY442303 mRNA. Translation: AAS13400.1. AY358352 mRNA. Translation: AAQ88718.1. AK026071 mRNA. Translation: BAB15349.1. AL391476 Genomic DNA. Translation: CAI12739.1. CH471122 Genomic DNA. Translation: EAW56672.1. BC074729 mRNA. Translation: AAH74729.1. DQ836392 mRNA. Translation: ABI16083.1. |
| IPI | IPI00479574. IPI00640575. IPI00644574. |
| RefSeq | NP_078902.2. NM_024626.2. |
| UniGene | Hs.546434. |
3D structure databases | |
| HSSP | HSSP built from PDB template 1PKO based on UniProtKB Q63345. |
| ProteinModelPortal | Q7Z7D3. |
| SMR | Q7Z7D3. Positions 35-246. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | Q7Z7D3. |
Polymorphism databases | |
| DMDM | 74759262. |
Proteomic databases | |
| PRIDE | Q7Z7D3. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000369458; ENSP00000358470; ENSG00000134258. |
| GeneID | 79679. |
| KEGG | hsa:79679. |
| UCSC | uc001ehb.1. human. uc009whf.1. human. |
Organism-specific databases | |
| CTD | 79679. |
| GeneCards | GC01M117686. |
| H-InvDB | HIX0000935. |
| HGNC | HGNC:28873. VTCN1. |
| MIM | 608162. gene. |
| neXtProt | NX_Q7Z7D3. |
| PharmGKB | PA142670611. |
| GenAtlas | Search... |
Phylogenomic databases | |
| GeneTree | ENSGT00530000063710. |
| HOVERGEN | HBG097943. |
| InParanoid | Q7Z7D3. |
| OrthoDB | EOG4MGS84. |
| PhylomeDB | Q7Z7D3. |
Gene expression databases | |
| ArrayExpress | Q7Z7D3. |
| Bgee | Q7Z7D3. |
| CleanEx | HS_VTCN1. |
| Genevestigator | Q7Z7D3. |
Family and domain databases | |
| InterPro | IPR007110. Ig-like. IPR013783. Ig-like_fold. IPR003599. Ig_sub. IPR013106. Ig_V-set. [Graphical view] |
| Gene3D | G3DSA:2.60.40.10. Ig-like_fold. 2 hits. |
| KO | K06747. |
| Pfam | PF07686. V-set. 1 hit. [Graphical view] |
| SMART | SM00409. IG. 1 hit. [Graphical view] |
| PROSITE | PS50835. IG_LIKE. 2 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 68926. |
| SOURCE | Search... |
Entry information
| Entry name | VTCN1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q7Z7D3 Secondary accession number(s): Q0GN76 Q9H6B2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with